Taysha Gene Therapies, Inc.
USD5.69
-0.28 (-4.69%)
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.88
Prev. Close
$5.97
Day Low
$5.62
Day High
$5.92
52W Low
$2.25
52W High
$7.30
Market Cap
$1.42B
Volume
1.49M
| 200,000 |
| $4.46 |
| 13 Apr 2026 | Nagendran Sukumar | director, officer: President and Head of R&D | M-Exempt | Disposed | 19,021 | $1.71 |
| 6 Feb 2026 | Alam Kamran | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 1,655 | $4.52 |
| 27 Jan 2026 | Nagendran Sukumar | director, officer: President and Head of R&D | S-Sale | Disposed | 89,132 | $4.75 |
| 27 Jan 2026 | Nagendran Sukumar | director, officer: President and Head of R&D | S-Sale | Disposed | 26,918 | $4.61 |
| 27 Jan 2026 | Nolan Sean P. | director, officer: Chief Executive Officer | S-Sale | Disposed | 41,312 | $4.61 |
| 27 Jan 2026 | Nolan Sean P. | director, officer: Chief Executive Officer | S-Sale | Disposed | 136,789 | $4.75 |
| 27 Jan 2026 | Alam Kamran | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 23,849 | $4.61 |
| 27 Jan 2026 | Alam Kamran | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 78,968 | $4.75 |